Cited by 208Probiotics and Fermented FoodsBacterial Cancer TherapyGut microbiota and health

The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.

Probiotics and colon cancer

Rafter, Joseph·2003·Best Practice & Research Clinical Gastroenterology

Abstract

Although a myriad of health-promoting effects have been attributed to the probiotic lactic acid bacteria, perhaps the most interesting and controversial is that of anticancer activity, the vast majority of studies in this area dealing with protective effects against colon cancer. There is no direct experimental evidence for cancer suppression in humans as a result of the consumption of probiotic cultures in fermented or unfermented dairy products, but there is a wealth of indirect evidence, based largely on laboratory studies. Reports in the literature regarding the anticancer effects of lactic acid bacteria fall into the categories of in vitro studies, animal studies, epidemiological studies and human dietary intervention studies. Examples of these reports will be given in the current paper. The mechanisms by which probiotic bacteria may inhibit colon cancer are still poorly understood, but, several potential mechanisms are being discussed in the literature, and these will also be addressed in this review.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1521-6918(03)00056-8

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 71 references

Research works printed but not linked: 10

  1. Friend, 1982, Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor, Milch Wissenschaft, 37, 708
  2. 1977, Dietary fibre, transit time, fecal bacteria, steroids, and colon cancer in two Scandinavian populations, Lancet, 2, 207
  3. Kulkarni, 1994, Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase, Proceedings of the Society of Experimental Biology and Medicine, 207, 278, 10.3181/00379727-207-43817 · DOI
  4. Abdelali, 1995, Effect of dairy products on initiation of precursor lesions of colon cancer in rats, Nutrition in Cancer, 24, 121, 10.1080/01635589509514400 · DOI
  5. Rowland, 1998, Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats, Carcinogenesis, 19, 281, 10.1093/carcin/19.2.281 · DOI
  6. Shahani, 1980, Role of dietary lactobacilli in gastrointestinal microecology, American Journal of Clinical Nutrition, 33, 2448, 10.1093/ajcn/33.11.2448 · DOI
  7. Sekine, 1985, A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice, Cancer Research, 45, 1300
  8. De Simone, 1993, The role of probiotics in modulation of the immune system in man and in animals, International Journal of Immunotherapy, 9, 23
  9. Pool-Zobel, 1996, Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats, Nutrition in Cancer, 26, 365, 10.1080/01635589609514492 · DOI
  10. Challa, 1997, Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats, Carcinogenesis, 18, 517, 10.1093/carcin/18.3.517 · DOI

Cited by

Sorted by citations

Items 201–208 of 208

Metadata

Authors
Rafter, J.
Affiliations
Karolinska Institutet (SE)
Corresponding author
Rafter, Joseph
Venue
Best Practice & Research Clinical Gastroenterology
Publisher
Elsevier BV
Published
2003-10
Volume
17
Issue
5
Pages
849-859
ISSN
1521-6918 (ISSN-L)
OpenAlex
W2062681903
Cited by
208
References
71
Citations by year
2026: 4 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 4 · 2017: 7 · 2016: 18 · 2015: 14 · 2014: 18 · 2013: 16 · 2012: 12
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Locations
  • Best Practice & Research Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, lactic acid bacteria, colon cancer, anticancer activity, chemoprevention, fermented dairy products, dietary intervention
MeSH terms
Animals, Colonic Neoplasms, Humans, Intestines, Lactobacillus, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review